- Vaccines
- Pharmaceuticals
- Analgesics
- Anti-infective
- Anti-inflammatory
- Parasiticides
- Others
- Feed Additives
- Medicinal
- Nutritional
Cattle Healthcare Market size was valued at 3.0 billion in 2021 and is estimated to reach 5.1 billion by 2028, at a CAGR of 7.9% during the forecast period 2022 to 2028. Some of the key factors fueling the market growth include increasing spending’s on R&D in the cattle health sector, rapid growth in population coupled with urbanization, growing production of beef, spreading of diseases through cattle and rising initiatives by governments and insurance policies in different countries. However, lack of infrastructure and regulatory challenges are inhibiting the market growth. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global cattle healthcare market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global cattle healthcare market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). The toxoids or killed vaccinations are available for a variety of diseases and are known to produce adverse reactions. The chemically altered vaccinations produce similar results as the live vaccines that have been modified. The vaccine industry is expanding its reach thanks to rising cow populations, more R&D spending, and new technologies. Vaccinations for respiratory infections, clostridial vaccines, botulism vaccines, and vaccinations for diseases that cause infertility or abortion in cattle are all available on the market.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Appetite for meat is growing at a faster rate than the world population. Growing household incomes are providing many consumers the capability to increase protein consumption, with those shifting into the middle-upper income brackets often seeking to expand the quality of meat they consume. Internationally, both the overall amount of meat consumed and average per capita consumption are greater than ever before. Beef has a long history of consumption in many markets around the world and constitutes a major part of diets in some countries. Hence, cattle healthcare is being driven by the increasing beef consumption.
Asia Pacific accounted for larger revenue share in global cattle healthcare market with considerable CAGR. The growth in this region can be attributed to increasing investments on research & development, rising healthcare infrastructure, growing ownership of livestock together with growing occurrences of disease outbreaks, increasing awareness by government authorities for veterinary health. North America held substantial market share during estimated period owing to huge requirement of cattle population and advanced technologies leading to innovations in the cattle health sector.
Latin America
Europe
Asia Pacific
Middle East
North America
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.